Abstract:In the search for inhibitors of COVID-19, we have targeted the interaction between the human angiotensin-converting enzyme 2 (ACE2) receptor and the spike receptor binding domain (S1-RBD) of SARS-CoV-2. Virtual screening of a library of natural compounds identified Kobophenol A as a potential inhibitor. Kobophenol A was then found to block the interaction between the ACE2 receptor and S1-RBD in vitro with an IC50 of 1.81 ± 0.04 μM and inhibit SARS-CoV-2 viral infection in cells with an EC50 of 71.6 μM. Blind docking calculations identified two potential binding sites, and molecular dynamics simulations predicted binding free energies of −19.0 ± 4.3 and −24.9 ± 6.9 kcal/mol for Kobophenol A to the spike/ACE2 interface and the ACE2 hydrophobic pocket, respectively. In summary, Kobophenol A, identified through docking studies, is the first compound that inhibits SARS-CoV-2 binding to cells through blocking S1-RBD to the host ACE2 receptor and thus may serve as a good lead compound against COVID-19.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jpclett.0c03119?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jpclett.0c03119</a>.Percent of hydrogen bonding occupancy over the MD simulation of the interactions between the ACE2 and S1- RBD regions when Kobophenol A was bound; illustration of the initial conformation of Y495 of S1-RBD and K353 of ACE2 domain in the reported crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M0J">6M0J</a>); distance computed from MD simulations between the O of the hydroxy group in Y495 in S1-RBD and N of the ammonium group for K353 in the ACE2 domain of the complex; light absorption at 450 nm, representing the amount of human ACE2 bound to the spike protein in the ELISA assay; additional EC50 curve of Kobophenol A antiviral activity in cell infected with SARS-CoV-2; chemical structure of natural compounds of Table 1; data sheets of human ACE2, spike RBD, and Kobophenol A (<a class="ext-link" href="/doi/suppl/10.1021/acs.jpclett.0c03119/suppl_file/jz0c03119_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

The Inorganic Polymer, Polyphosphate, Blocks Binding Of Sars-Cov-2 Spike Protein To Ace2 Receptor At Physiological Concentrations

An Unexpected Biomaterial Against SARS-CoV-2: Bio-polyphosphate Blocks Binding of the Viral Spike to the Cell Receptor.

The Biomaterial Polyphosphate Blocks Stoichiometric Binding of the SARS-CoV-2 S-protein to the Cellular ACE2 Receptor.

Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.

The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19)

Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro

Morphogenetic (Mucin Expression) As Well As Potential Anti-Corona Viral Activity Of The Marine Secondary Metabolite Polyphosphate On A549 Cells

Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro

Inorganic Polyphosphate: Coacervate Formation and Functional Significance in Nanomedical Applications

Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD

Inorganic polyphosphates: biologically active biopolymers for biomedical applications.

Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions Between SARS-CoV-2 Spike Protein and Human ACE2 Receptor

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions

Caged Dexamethasone/Quercetin Nanoparticles, Formed of the Morphogenetic Active Inorganic Polyphosphate, are Strong Inducers of MUC5AC

Inorganic Polymeric Phosphate/polyphosphate As an Inducer of Alkaline Phosphatase and a Modulator of Intracellular Ca2+ Level in Osteoblasts (Saos-2 Cells) in Vitro.

Caged Dexamethasone/Quercetin Nanoparticles, Formed of the Morphogenetic Active Inorganic Polyphosphate, are Strong Inducers of MUC5AC.

1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection

Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays

An Inorganic Biopolymer Polyphosphate Controls Positively Charged Protein Phase Transitions.

Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19